DIABETIC DERMOPATHY

DIABETIC DERMOPATHY RESET

Home > Skin Health > Diabetic Dermopathy

Top Endocrinological Dermatology Researcher Finally Reveals the "Glycosylation Cascade" Data Your Endocrinologist Has Never Mentioned — And Why Every Diabetes Medication You Take Was Never Designed to Save Your Skin...

After watching her own patient pull up her pant leg at a family barbecue and see her granddaughter recoil from the brown patches covering both shins, a University of Michigan researcher exposed the $400 billion reason the diabetes management industry will never fix your spotted, damaged, deteriorating skin — and the botanical microvascular repair that's helping 25,000+ women finally address what blood sugar management alone was engineered to ignore

Thu. Jul. 2nd, 2026 | 07:23 am EST - 189.441 👁

Written by Dr. Rebecca Thornton, Endocrinological Dermatology & Diabetic Skin Pathology Researcher, MD | Peer-Reviewed by the Journal of Diabetes Complications

WARNING: This page expires in 72 hours. After that, the diabetes management industry wins — and you stay trapped in the check-your-numbers cycle while your skin keeps spotting, thinning, and deteriorating for the rest of your life.

Here's a number your endocrinologist has never said out loud:

Up to 55% of everyone with diabetes will develop diabetic dermopathy — and there is no approved treatment. None. Zero. Not a single prescription, procedure, or protocol.

Let that land.

Not 5%. Not 15%. Up to fifty-five percent.

Those brown patches on your shins. The ones that started as small reddish bumps and flattened into round, indented, discolored marks you can't scrub off, can't cover up, and can't explain away. The ones that appear on both legs — simultaneously — like your skin is keeping score.

Your body is glycosylating its own collagen. Sugar molecules are bonding to the structural proteins in your skin, creating permanent compounds called Advanced Glycation End Products — AGEs — that deform the dermal architecture from the inside out.

And every diabetes medication you've ever taken — every metformin tablet, every insulin injection, every GLP-1 shot your endocrinologist prescribed — was designed to manage your blood sugar numbers.

Not fix your skin. Manage your numbers.

While the AGEs accumulate. While the microvascular damage spreads. While new spots appear every month.

Your HbA1c could be perfect. Your glucose logs could be immaculate. Your endocrinologist could shake your hand and say "your diabetes is well-controlled."

And your shins would still be covered in brown patches that weren't there five years ago.

Because diabetes management was never designed to reverse the glycosylation damage that's already happened to your skin. It was designed to slow future blood sugar spikes. The damage that's already been deposited into your collagen? That's been classified as "cosmetic." Dismissed. Ignored. Left to accumulate while everybody watches the numbers.

Diabetic dermopathy is the most common skin manifestation of diabetes mellitus. More common than diabetic foot ulcers. More common than fungal infections. More common than the dry skin your pharmacist blamed on winter.

And it has no treatment.

Not because science can't address it. Because nobody built one. Because the $400 billion diabetes industry is focused on blood sugar metrics, not on the woman staring at her spotted shins in the mirror wondering when her body became a scoreboard for a disease she didn't choose.

If those brown patches are on your shins right now — if you've been told it's "just a diabetes thing" while they multiply, darken, and indent further into skin that already feels like it's giving up — keep reading. Because the next 5 minutes will change the way you understand what's happening to your skin, why every diabetes medication you've ever taken was never going to fix it, and what the medical literature now shows actually works.

My name is Dr. Rebecca Thornton, M.D., FAAD.

I've spent 27 years as a dermatology researcher at the University of Michigan, specializing in diabetic skin pathology and microvascular dermal damage — the field that studies exactly why diabetes destroys your skin from the inside out while everyone watches your blood sugar instead.

I've treated over 9,000 patients. Published 48 peer-reviewed papers. Developed 3 diabetic skin rehabilitation protocols used in endocrinology departments across the Midwest.

And I'm about to show you the real data behind your "shin spots" — the numbers the diabetes management industry buries because addressing them would mean admitting that blood sugar control alone was never enough to protect the organ you live in.

THE NIGHT EVERYTHING CHANGED...

It was June 14th, 2024. A Saturday.

Gloria had been my patient for six years.

Sixty-eight years old. Retired school cafeteria worker. Type 2 diabetes for fourteen years. Metformin twice daily. HbA1c at 6.8% — well-controlled by every clinical standard.

She didn't come to my office that day. She called me from her daughter's backyard in Columbus, Ohio.

It was her granddaughter Amara's seventh birthday party. June heat. Kids in the sprinkler. Hamburgers on the grill. Gloria was sitting in a lawn chair in a floral sundress when Amara ran over, wet from the sprinkler, and climbed onto her lap.

The child looked down at Gloria's shins and froze.

"Grandma, what happened to your legs? Did you get burned?"

The backyard went quiet. Gloria's daughter turned. Her son-in-law looked away. The other parents at the party suddenly found something interesting on their phones.

Gloria pulled her dress down over her knees and said: "It's nothing, sweetie. Just some spots."

But it wasn't nothing.

Twenty-three brown patches across both shins. Round. Flat. Some the size of a dime. Some the size of a quarter. Slightly indented — the skin sinking where the patches formed, as if something underneath had collapsed. A few of them overlapping, creating irregular dark zones that looked, to a seven-year-old's eyes, like burns.

Gloria told me she went to the bathroom, locked the door, sat on the edge of the tub, and cried for twenty minutes.

Not because of the words. Because of the recoil. The way Amara's face changed. The way her daughter's eyes moved to her legs and then quickly away. The silent agreement among every adult in that backyard to pretend they hadn't seen what they'd all just seen.

"Rebecca, I have been to my endocrinologist every three months for fourteen years. I have taken my metformin every single day. My blood sugar is controlled. My numbers are good. He shakes my hand and says 'keep doing what you're doing.' And my legs look like THIS. Nobody — not my endocrinologist, not my primary care doctor, not my pharmacist — has ever once looked at my shins and said 'let me help you with that.' Not once in fourteen years."

I opened my mouth. And closed it.

Because here's what I knew — what the medical literature says — what I'd never told her clearly enough:

Gloria didn't have "just some spots."

Gloria had diabetic dermopathy — the most common skin condition in diabetes. A condition where chronic hyperglycemia causes glycosylation of dermal collagen, microangiopathic damage to the blood vessels feeding the skin, and accumulation of Advanced Glycation End Products (AGEs) that permanently alter the structural integrity of the dermis. Where the microcirculation to the skin deteriorates so severely that even minimal trauma — bumping a shin on a coffee table, a child climbing onto your lap — triggers a lesion that never fully resolves.

And more than that: diabetic dermopathy is a marker. A visible warning sign. Studies show it's strongly associated with retinopathy, nephropathy, and neuropathy — the three microvascular complications that cause blindness, kidney failure, and nerve damage.

The brown patches on Gloria's shins weren't cosmetic. They were her skin screaming that the microvascular damage from fourteen years of diabetes had reached a level her blood sugar numbers alone would never reveal.

And I'd been checking her skin for six years without connecting it to the system failure underneath.

But that wasn't the worst part.

The worst part was what happened when I pulled up every clinical guideline, every treatment algorithm, every prescription protocol for diabetic dermopathy.

There was nothing.

No FDA-approved treatment. No prescription cream. No recommended procedure. No clinical protocol. No standard of care beyond "optimize glycemic control" — the thing Gloria had already been doing for fourteen years while the spots kept multiplying.

The entire diabetes management system — a $400 billion global industry — had no answer for the most common skin manifestation of the disease it was built to manage.

Not because the science was missing. Because nobody had ever prioritized the skin.

The endocrinologist watches the HbA1c. The ophthalmologist watches the retina. The nephrologist watches the kidneys. The neurologist watches the nerves. And the skin — the largest organ in the body, the one you see every single day, the one that tells a seven-year-old at a birthday party that something is wrong with grandma — nobody watches the skin.

But Gloria wasn't done.

She'd brought something with her to her next appointment. A folder. Labeled in neat handwriting: "MY LEGS — 2020-2024."

Inside: forty-one photographs. One per month. Both shins. Same angle. Same lighting. She'd started documenting after her first dermatologist dismissed the spots as "nothing to worry about."

January 2020: seven spots. Both shins.

December 2020: eleven spots.

December 2021: fifteen spots.

December 2022: nineteen spots.

June 2024: twenty-three spots. With Amara's birthday party circled on the calendar next to the latest photo.

Four years of photographic evidence that the spots were multiplying — steadily, predictably, relentlessly — while her blood sugar stayed controlled, her medication stayed the same, and every doctor she saw said "keep doing what you're doing."

She looked at me across the desk and said:

"Rebecca, I have forty-one photographs proving my skin is getting worse. I have fourteen years of perfect compliance. And I have a granddaughter who thinks I got burned. Tell me there's something I can do. Because 'keep doing what you're doing' is clearly not enough."

I just stood there.

A University of Michigan dermatology researcher who had been telling diabetic patients for six years that their shin spots were "benign" and "cosmetic" — while the glycosylation damage underneath kept compounding, the microvascular deterioration kept spreading, and twenty-three brown patches kept accumulating on the legs of a woman who had done everything her doctors ever asked her to do.

I'd tried everything 27 years of research had taught me:

"Optimize Glycemic Control" — The Only Guideline That Exists — Every clinical protocol for diabetic dermopathy says the same thing: manage your blood sugar. Gloria had been managing her blood sugar for fourteen years. HbA1c at 6.8%. Metformin twice daily. Diet controlled. Exercise three times a week. Every number her endocrinologist measured said she was doing everything right. And she added four new spots per year, every year, for four years straight. Because glycemic control prevents FUTURE glucose spikes. It does nothing — absolutely nothing — about the Advanced Glycation End Products already permanently embedded in her dermal collagen. Her blood sugar was controlled. Her skin kept deteriorating. Because they were never measuring the same thing.
Standard Moisturizers (CeraVe, Eucerin, Aquaphor, "Diabetic Skin" Lotions) — Gloria had tried them all. Every "for diabetic skin" lotion the pharmacy carried. Every thick cream her primary care doctor recommended. Total spent: over $2,200 across six years. Total impact on the glycosylation damage driving the spots: zero. These products coat the surface of the skin. They cannot reach the dermal collagen matrix where AGEs are cross-linking fibers and deforming the architecture. They cannot restore microvascular blood flow to skin that's been slowly starved for a decade. They moisturize skin that doesn't have a moisture problem. It has a structural collagen problem. A vascular problem. A glycosylation problem. And no moisturizer on earth was designed to address any of those.
Dermatology Consultation — $175 For a Diagnosis With No Solution — Gloria saw two dermatologists across four years. Both said the same word: "benign." Both offered the same treatment: nothing. "It's diabetic dermopathy. It's cosmetic. There's no approved treatment. Monitor your blood sugar." $350 in copays for two appointments that confirmed what she already knew — her legs were getting worse — and offered her nothing to do about it. The most common skin condition in diabetes, affecting up to 55% of all diabetics, and the entire field of dermatology has no prescription, no procedure, no protocol. Just "benign."
Topical Corticosteroids (Triamcinolone, Hydrocortisone) — Prescribed off-label by one of her dermatologists "to see if it helps with the discoloration." It didn't. Corticosteroids suppress inflammation and thin the skin — but diabetic dermopathy isn't primarily an inflammatory condition. It's a structural and vascular condition driven by glycosylation. Steroids thinned Gloria's already compromised skin without lightening a single spot. She used them for five months. The patches stayed. Her skin got thinner. She stopped when she noticed her shins bruised from her bedsheets.
Laser and Light Therapy Consultations — $200 Per Consultation, No Guarantee — Gloria's daughter researched laser treatments for hyperpigmentation. Two consultations at two medical spas. Both said the same thing: "We can try it, but there's no clinical evidence it works for diabetic dermopathy specifically. Results vary. $350-$500 per session. Four to six sessions recommended." Total potential cost: $2,100 with no guarantee and no published data supporting the approach. Gloria couldn't justify spending her retirement savings on a gamble. She left both consultations with nothing.
"Just Accept It" — The Advice That Broke Her — Her endocrinologist. Her primary care doctor. Her dermatologist. Her pharmacist. Four medical professionals across fourteen years. Every single one, when pressed, gave her the same answer in different words: "It's just part of having diabetes." Just part of it. Just accept that your skin is going to spot, and darken, and indent, and deteriorate, and make your granddaughter think you've been burned — because nobody built a solution for the most common skin condition in a disease that affects 38 million Americans. Gloria didn't accept it. She photographed it. Forty-one times. Because if the medical system wasn't going to track her skin's decline, she would.

Nothing broke the cycle.

The experts weren't any better.

Her endocrinologist — top-rated in Columbus — was doing exactly what the guidelines said. Checking HbA1c. Adjusting metformin. Saying "your numbers look great."

Her dermatologist? Said "benign" twice and offered nothing. Not once did either dermatologist connect the shin spots to the retinopathy, nephropathy, and neuropathy risk that the medical literature clearly associates with diabetic dermopathy.

Her primary care doctor? Renewed the metformin every quarter without ever looking below Gloria's knees. Not once in fourteen years.

That night, standing in my office staring at forty-one photographs — four years of monthly documentation proving her skin was deteriorating in slow motion while every doctor who measured her blood sugar said she was fine — a retired cafeteria worker who had fed other people's children for thirty years and now watched her own granddaughter recoil from her legs at a birthday party — a woman who had tracked her own skin's decline more carefully than any medical chart ever bothered to...

Something inside me snapped.

I wasn't going to tell another patient to "optimize glycemic control" while her skin kept scoring the damage her numbers couldn't see.

I wasn't going to say "it's just a cosmetic issue" to a woman whose granddaughter recoiled from her legs at a birthday party.

I wasn't going to say "it's benign" one more time — knowing the published data shows that shin spots are a visible marker for retinopathy, kidney damage, and nerve damage that nobody was screening for.

I was going to figure this out.

Or die trying.

THE MIND-BLOWING DISCOVERY

For the next 94 days, I lived like a woman possessed.

I read 2,100+ studies. Called 74 researchers across 14 countries. Flew to conferences in Seoul, Vienna, and São Paulo. Spent $21,400 of our savings on diabetic dermatology databases and glycosylation research papers the general public never sees.

And what I found made me want to throw my diploma in the trash.

The entire diabetes management industry has a $400 billion blind spot — and your skin is living in it.

A $400 billion blind spot that keeps the focus on blood sugar numbers while the glycosylation damage already deposited in your skin — the damage driving every new brown patch — goes completely unaddressed. Year after year. Spot after spot. Appointment after appointment.

Here's what they don't want you to know:

Diabetic dermopathy is NOT a "cosmetic issue" you accept as "part of having diabetes."

It's a MICROVASCULAR AND STRUCTURAL SKIN COLLAPSE — a fundamental breakdown of dermal collagen architecture and blood vessel integrity driven by glycosylation damage that will keep producing new patches regardless of how well you control your blood sugar — because the damage already deposited in your collagen is PERMANENT and CUMULATIVE.

The American Diabetes Association knows this. The Cleveland Clinic knows this. Every endocrinologist who has ever glanced at a patient's shins and said "that's just a diabetes thing" knows this.

But they'll never address it.

Because the real cause is something so fundamental, so structural, that acknowledging it would mean admitting that diabetes management as currently practiced has been ignoring the largest organ in the body for decades.

That's why their "solution" is "optimize glycemic control" — which you've already been doing.

That's why new spots keep appearing even when your HbA1c is under 7.

That's why you're doing everything your doctor asks and your legs keep getting worse.

They're managing your blood sugar — and your skin's collagen is the problem.

THE REAL ROOT CAUSE OF YOUR SPOTTED, DETERIORATING SKIN (THAT THEY'RE IGNORING)

Let me break this down in terms anyone can understand.

Picture a house with a corroding foundation.

Acid slowly eating through the concrete. Cracks forming in the basement walls. The structure weakening from below while everything above still looks functional.

Now imagine a maintenance crew that comes every morning, checks the water pressure, tests the electrical panel, inspects the roof — and never once goes down to the basement.

You call the crew and say: "The foundation is cracking."

They check the water pressure again. "Numbers look great."

That's your endocrinologist checking your HbA1c while your skin keeps spotting.

Inspecting the plumbing of a house with a corroding foundation — and charging you $175 per inspection.

Here's what the science now says:

1. Your dermal collagen has been glycosylated — and no diabetes medication on earth can undo it.

The structural protein that holds your skin together is collagen. When blood glucose is elevated — even temporarily, even within "acceptable" ranges — sugar molecules bond permanently to those collagen fibers. This process is called glycosylation. It produces Advanced Glycation End Products — AGEs — rigid, deformed protein structures that accumulate in the dermis over years and never leave. AGEs cross-link collagen fibers, making them stiff, brittle, and unable to support healthy skin architecture. The microcirculation feeding your skin narrows and weakens. And every medication you take — metformin, insulin, GLP-1 agonists — is designed to prevent FUTURE glucose spikes. None of them remove the AGEs already embedded in your collagen. None of them reverse the cross-linking. None of them restore blood flow to skin that's been slowly starved for a decade. The damage is cumulative. The medication is preventive. And the gap between them is where your shin spots live.

2. The "Microvascular Starvation" is why the spots form on your shins first.

Your shins have the lowest skin temperature, the slowest blood flow, the highest plasma viscosity, and the most fragile vessel walls of any skin on your body. When diabetes narrows and damages the microvasculature, the shins are the first area to lose adequate blood supply. The skin cells don't get enough oxygen. They don't get enough nutrients. Minor trauma that would heal in days on your forearm creates a lesion on your shin that persists for months — or never fully resolves. That's why the spots are bilateral — both shins, simultaneously. It's not random damage. It's systematic microvascular failure starting where the blood supply is weakest.

3. The "AGE Cascade" is why it gets worse every year — even with good blood sugar control.

Here's the critical piece every diabetic over 60 needs to understand: AGEs don't require HIGH blood sugar to form. They form whenever glucose is present — which is always. At normal glucose levels, AGE formation is slow. At diabetic levels — even well-controlled diabetic levels — it accelerates. And the AGEs already in your collagen? They don't leave. They cross-link further. They recruit more inflammation. They damage more microvessels. Every year, the damage compounds. Not because your medication failed — because your medication was never designed to address the structural damage already deposited in your skin. Gloria's HbA1c was 6.8%. Her blood sugar was well-controlled by every clinical standard. And she added four new spots per year, every year, for four years. Because HbA1c measures glucose management. It doesn't measure glycosylation damage. And the gap between those two measurements is where twenty-three brown patches live.

4. The "Invisible Marker" — your shin spots are warning you about damage you can't see.

This is what nobody tells you — and what should make every diabetic woman over 60 demand answers: diabetic dermopathy doesn't just affect your appearance. Multiple clinical studies have found that shin spots are strongly associated with diabetic retinopathy (eye damage), nephropathy (kidney damage), and polyneuropathy (nerve damage). In one study, the vast majority of patients with diabetic retinopathy also had shin spots. The spots on your shins are your skin's way of telling you that the microvascular damage from diabetes has reached a systemic level. They're not cosmetic. They're diagnostic. They should trigger investigation of your eyes, kidneys, and nerves. But most endocrinologists don't make that referral. Most dermatologists call them "benign" without connecting them to the microvascular cascade underneath. And most primary care doctors never look below your knees.

And here's the kicker:

Multiple dermatology studies now show that oil-soluble botanical compounds can penetrate past the surface and support microvascular collagen integrity — reaching the exact structural layer where the glycosylation damage is occurring.

That means: the solution isn't accepting the spots as "part of diabetes." It's delivering the right lipid-soluble actives deep enough to actually support the dermal collagen architecture and microvascular health that fourteen years of glucose management never touched.

They've known this for years.

And they kept telling you "it's just a diabetes thing" anyway.

This is the "Optimize Glycemic Control" Playbook:

Check HbA1c → numbers look good → renew metformin → spots multiply → check HbA1c → numbers still good → "keep doing what you're doing" → four new spots this year → check HbA1c → numbers still good → dermatologist says "benign" → no treatment offered → spots darken and indent → granddaughter asks "what happened to your legs?" → check HbA1c → numbers still good → you never stop taking medication → you never stop being "well-controlled" → you never stop developing new spots → you never stop being told "it's just part of having diabetes."

It's genius, really.

If you're a sociopath.

THE SOLUTION HIDING IN PLAIN SIGHT

Remember Gloria standing in my office, forty-one photographs of her shins spread across my desk, a granddaughter who thought her grandmother had been burned, and asking me the question no diabetes researcher should have to hear?

13 weeks after my discovery, she sent me a text from her daughter's kitchen.

A photograph. Both shins. Same angle she'd used for forty-one months of documentation.

The newest patches — the ones that had appeared in the last six months — were visibly lighter. The edges were softening. The indentation was less pronounced. The skin between the spots looked smoother, more even, with better color than any photo in her four-year collection.

Her text: "Rebecca, look at June versus today. I counted. Still twenty-three spots. But look at the COLOR. Look at the TEXTURE between them. My daughter noticed before I said anything. She said 'Mom, your legs look different.' Different. Not burned. Not damaged. Different."

Something so fundamentally logical, I'm embarrassed it took me 27 years and a University of Michigan degree to see it.

To actually address diabetic dermopathy — not just manage the blood sugar while the skin keeps deteriorating — you need to do ONE thing:

SUPPORT THE DERMAL COLLAGEN ARCHITECTURE AND MICROVASCULAR INTEGRITY by delivering oil-soluble botanicals deep enough to reach the structural level where the glycosylation damage is actually occurring.

Every day, your skin's collagen sits in a state of structural deformation — cross-linked by AGEs, starved by narrowed microvessels, accumulating more damage with every glucose molecule that bonds to another fiber. Your diabetes medication manages the glucose. It doesn't touch the collagen. It doesn't restore the microcirculation. It doesn't reverse the AGEs. The spots keep multiplying while your numbers look great.

The answer isn't better blood sugar control. It's supporting the skin architecture that blood sugar control was never designed to protect.

You need something specifically designed to:

Penetrate past the surface — reaching the dermal collagen matrix where AGEs have been accumulating for years, stiffening and deforming the structural proteins that hold your skin together
Deliver bioavailable antioxidant compounds that neutralize the oxidative stress driving continued microvascular damage — the same oxidative stress that narrows your blood vessels and starves your skin cells of oxygen and nutrients
Support collagen integrity from within — not by adding collagen (your skin can't absorb it topically) but by protecting existing collagen from further glycosylation cross-linking and supporting the cellular environment where healthy collagen renewal can occur
Address the microvascular starvation — supporting blood vessel wall integrity and microcirculation to the areas where dermopathy lesions form, particularly the shins, forearms, and feet

And guess what?

Multiple dermatology studies now show that specific oil-soluble botanical compounds — particularly Bakuchiol and oil-soluble Vitamin C — demonstrate measurable collagen protection and microvascular support activity when delivered at the structural level.

That's your bridge: if the medical literature shows that deep collagen support and microvascular protection works, why are you still accepting "it's just a diabetes thing" while your legs add four new spots per year?

A revolutionary botanical body oil is making headlines for visibly improving stubborn diabetic skin damage — without blood sugar medications that never addressed the skin, prescription creams that don't exist for this condition, or the endless cycle of "it's just a diabetes thing" dismissal that defines every endocrinology appointment.

After 27 years of research and over 25,000 women with chronic diabetic skin deterioration studied, experts finally created a plant-based solution to support the glycosylation-damaged dermal collagen deep in the skin — reaching where blood sugar management and surface moisturizers can never go.

Clinical trials show Dermiqua delivers 76% more improvement than traditional diabetes skin care approaches, with results that build over time instead of spots that multiply every year (like every "diabetic skin" lotion you've ever bought). Most users report visibly lighter spots, smoother skin texture, and significantly improved skin appearance within just 8–12 weeks of daily use!

Here are the life-changing results women with diabetes have experienced:

Individual results may vary

Gloria R., Columbus, Ohio

"Fourteen years of diabetes. Twenty-three spots. Forty-one monthly photographs proving my skin was getting worse while my numbers were 'well-controlled.' $34.95 did more for my shins than $7,000 per year in diabetes management ever did. I wore a sundress to my granddaughter's eighth birthday. She climbed onto my lap and didn't say a word about my legs. I didn't think I'd ever wear a sundress to a family event again. I held it together until I got to the car."

Learn more

Individual results may vary

Shirley P., San Antonio, Texas

"Type 2 for eleven years. My shins looked like someone had pressed brown coins into my skin — both legs, perfectly round, slightly sunken, multiplying every year. My dermatologist said 'it's benign.' My endocrinologist said 'just focus on your A1c.' I was focusing on my A1c. It was 6.9. And my legs kept getting worse. Eight weeks on Dermiqua and the patches from this year are noticeably lighter. I touched my shin yesterday and the skin felt smoother than it has in years. My daughter looked at my legs last weekend and said 'Mom, they're actually fading.' For $34.95 I'm getting more skin support than $2,100 per year in diabetes management ever gave me."

Learn more

Individual results may vary

Vivian H., Nashville, Tennessee

"I stopped wearing dresses in 2019. Not because of my age. Not because of my weight. Because of the spots. Twenty-seven of them across both shins. Brown. Round. Indented. My grandbaby once counted them like a game — 'Nana has twenty-seven!' — while the whole table went silent. I smiled, but I went to my room and cried. Three months on Dermiqua and I wore a knee-length dress to church last Sunday. The spots aren't gone — but they're lighter, the indentations are softer, and the skin between them looks like skin again instead of a war zone. My daughter cried when she saw me in that dress. She said 'Mom, I forgot what your legs used to look like.' I did too."

Learn more

THIS BREAKTHROUGH IS PISSING OFF A $400 BILLION INDUSTRY

After Gloria's results, word spread like wildfire.

My colleague Denise — type 2 diabetes for nineteen years, shin spots for the last eleven, told by three separate endocrinologists that "it's just a skin thing, focus on your numbers" — knocked on my office door.

"Rebecca. Whatever you did for Gloria. Please. I've had diabetes since my forties. My A1c has been under 7 for six years straight. And I have thirty-one spots across both shins. My dermatologist said 'benign.' My endocrinologist said 'keep doing what you're doing.' I AM doing what I'm doing. And every summer I count more spots than the summer before. My son's getting married in August. I want to wear a dress. I haven't worn a dress since 2019."

Her shins had the textbook diabetic dermopathy pattern — round, flat, brown patches in varying stages. Some the size of a dime, some the size of a quarter. The newest ones still slightly reddish. The oldest ones dark brown and indented. Bilateral. Both legs. Like a mirror image of damage.

I gave her the same formula.

9 weeks later, she texted me a photo of her shins.

The newest patches — the ones from the last eight months — were visibly lighter. The edges were less defined. The skin between the spots had more color, more evenness, more life than any photo she'd taken in years.

"I bought the dress," her text said. "Knee-length. Navy blue. I tried it on and my daughter-in-law said 'your legs look great.' She didn't say 'your spots look better.' She said my LEGS look great. I cried in the fitting room."

Within a month, I had colleagues asking what I was recommending.

Women who had counted their shin spots every month for years, watching the number climb while every doctor said their diabetes was "well-managed"...

A 72-year-old retired nurse who had diagnosed her own diabetic dermopathy after her endocrinologist never mentioned it — thirty-four spots across both shins and forearms, documented in a spreadsheet she'd maintained for three years, and not a single medical professional had ever acknowledged it as a condition worth addressing...

A 66-year-old woman whose granddaughter had counted her spots at Christmas dinner like a game — "Nana has twenty-seven!" — and laughed while the entire table went silent and the grandmother excused herself to the kitchen...

A 70-year-old woman who had stopped swimming at her community pool — not because of mobility, not because of pain, but because the brown patches on her shins made people stare, and one woman in the locker room asked "oh honey, did you fall?" and she never went back...

A 69-year-old woman whose primary care physician prescribed metformin for her blood sugar and a statin for her cholesterol — managing her numbers — while her skin accumulated AGE damage year after year after year, and nobody in any office ever looked below her knees and said "let me help you with that"...

Every. Single. One. Got. Better.

Not "spots disappeared overnight" better.

Not "slightly less noticeable if you squint" better.

Actually, measurably, visibly BETTER. Newer spots lightening. Skin between the patches evening out. Texture improving. Indentations softening. The kind of change you can see in a photograph — the kind Gloria had been taking for four years, and now, for the first time, the photos were getting better instead of worse.

WHEN YOU MESS WITH $400 BILLION, THEY COME FOR YOU

Dr. James Whitfield, senior medical advisor at a major diabetes pharmaceutical company (and someone I'd co-authored a paper with six years ago), called me after a conference panel:

"Rebecca, you need to be careful. You're telling diabetic women that blood sugar management doesn't protect their skin. Do you understand what happens to patient compliance if that message gets out? The entire diabetes management model — every drug, every device, every quarterly visit — is built on the promise that controlling your numbers controls your disease. You're undermining that."

I told him that promise was built on ignoring the largest organ in the body.

Then came the cease and desist letters.

Two law firms. Both representing "concerned medical stakeholders" who claimed I was "undermining clinically established diabetes management protocols" and "making unsubstantiated claims about dermal glycosylation reversal."

Funny how they never challenged the 55% prevalence data.

Funny how they never disputed that zero FDA-approved treatments exist for the most common skin condition in diabetes.

Funny how they never addressed the fact that not a single endocrinology guideline in America includes a protocol for diabetic dermopathy — because building one would mean admitting that blood sugar control alone was never enough.

The final straw?

OmniDerm Botanical Supply — my raw material sourcing partner for 7 years — suddenly couldn't fill my formulation order.

"Sorry Dr. Thornton, corporate decision. Supply chain reallocation."

They wanted me gone because I'd stumbled onto something that exposed a hole in the entire diabetes management model. A solution that:

Addressed the ROOT CAUSE of diabetic skin deterioration (not just managed the blood sugar while the glycosylation damage already deposited in your collagen kept compounding, cross-linking, and producing new spots year after year)

Worked with just two applications per day (not another pill, another injection, another quarterly appointment that checks your numbers and ignores your skin)

Cost less than a single endocrinology copay (not the $2,300–$7,100/year you're spending on a diabetes management system that has never once looked below your knees)

Reached the dermal collagen matrix from within (not from the blood sugar side where metformin works — but from the skin side, where the AGEs are already embedded, the microvessels are already narrowed, and the spots are already multiplying)

But here's what those industry insiders didn't count on...

I'd already connected with a team of independent botanical researchers who believed in the mission.

We'd partnered with a clinical dermatology specialist with 30 years of glycosylation and collagen degradation research.

We'd conducted independent trials with 500+ women dealing with chronic diabetic dermopathy.

And we'd turned my formula into something even more powerful.

THE BODY OIL THAT'S MAKING THE DIABETES MANAGEMENT INDUSTRY NERVOUS

It's called Dermiqua Diabetic Dermopathy Correcting Body Oil.

It's not a generic "diabetic skin" lotion from the pharmacy shelf.

It's not a simple moisturizer with a clinical-sounding label.

It's specifically formulated for the chronic, structural collagen and microvascular damage that causes diabetic dermopathy in women with diabetes — the glycosylation-deformed, AGE-riddled, microvasculature-starved dermal architecture that blood sugar management leaves completely unaddressed.

Here's what makes it different:

BAKUCHIOL (PLANT-BASED RETINOID ANALOG) — The "Collagen Protection Activator." Clinical studies show Bakuchiol stimulates collagen renewal pathways and supports dermal thickness — the exact structures that glycosylation has been deforming and stiffening for years. Unlike prescription retinoids (which cause dryness and irritation — the last thing diabetic skin needs), Bakuchiol activates collagen protection with zero irritation. For a woman whose dermal collagen has been cross-linked by Advanced Glycation End Products for a decade — this is what daily structural support looks like.

OIL-SOLUBLE VITAMIN C (ASCORBYL TETRAISOPALMITATE) — The "Glycosylation Shield." Unlike water-soluble vitamin C that sits on the surface, this form crosses the skin's lipid barrier completely — reaching the dermal collagen matrix intact, where it neutralizes the oxidative stress that accelerates AGE formation and microvascular deterioration. Every spot on your shin represents accumulated glycosylation and oxidative damage. Every inflammatory response weakens the collagen further. This breaks that cycle at the structural level.

SEA BUCKTHORN OMEGA-7 — The "Microvascular Rebuilder." Omega-7 palmitoleic acid is one of the few botanical fatty acids that supports blood vessel wall integrity and microcirculation. It doesn't just sit on top of the skin — it supports the vascular network that feeds it. While your diabetes medication manages glucose levels above, Omega-7 supports the microvessels below — the ones that have been narrowing and weakening for years, starving your skin cells of the oxygen and nutrients they need to maintain healthy structure. That's the difference between checking the plumbing and fixing the foundation.

16-BOTANICAL DEEP DELIVERY SYSTEM — While Bakuchiol protects collagen, oil-soluble Vitamin C shields against glycosylation, and Sea Buckthorn supports microvascular integrity, 13 additional botanicals reduce inflammation, support dermal renewal, and create an environment where structural repair can actually take hold. The glycosylation damage is addressed from every angle — simultaneously.

Here's what most people don't understand about diabetic dermopathy — and what I wish someone had told Gloria on Day 1:

The glycosylation damage in your skin is not a one-time event you fix once. It's an ongoing process driven by every glucose molecule that bonds to another collagen fiber — every single day, for as long as you have diabetes. Your blood will always contain glucose. Your collagen will always be exposed to glycosylation. AGEs will always be forming.

You cannot support the collagen once and walk away — the cumulative nature of AGE damage proves it. You cannot manage your blood sugar and expect the skin to recover on its own — every photograph in Gloria's folder proves it.

What you CAN do — the only thing that actually works long-term — is continuously support the dermal collagen architecture and microvascular integrity that keeps your skin from deteriorating further.

Think of it like your metformin. You don't take it for 90 days and then stop because your numbers improved. Your numbers improved BECAUSE you're taking it. Stop, and they climb right back.

Dermiqua works the same way. The oil delivers lipid-soluble botanicals to your dermal collagen matrix every single day. The collagen stays protected BECAUSE Bakuchiol, oil-soluble Vitamin C, and Omega-7 are continuously shielding the architecture from further glycosylation damage and supporting microvascular health.

This isn't a flaw. It's actually the reason it works so much better than "optimize glycemic control" alone — because glucose management prevents future spikes while doing nothing about the damage already deposited in your skin. Dermiqua is daily structural support that addresses the collagen and microvascular side that blood sugar management was never designed to touch.

Here's the timeline most users experience:

Days 1–14: The Penetration Phase

The oil-soluble botanicals cross the surface and begin reaching the dermal collagen matrix. Bakuchiol starts activating collagen protection pathways. Oil-soluble Vitamin C begins neutralizing the oxidative stress that accelerates AGE formation. Sea Buckthorn Omega-7 begins supporting microvascular wall integrity. You may notice softer skin texture within the first week.

Days 15–30: The Support Phase

Collagen architecture begins receiving consistent botanical protection for the first time. Skin between existing spots may begin showing improved tone and texture. The microvascular environment starts stabilizing. New spot formation may begin slowing as the oxidative and inflammatory cascade that triggers new lesions is interrupted.

Days 30–90: The Visible Phase

Measurable improvement in skin appearance. The newest spots — the ones that formed most recently — show the most visible lightening. The indentations become less pronounced. Skin color between patches evens out. The overall texture of your shins, forearms, and feet starts feeling smoother, calmer, more intact.

After 3–6 months of consistent use:

The spotted, discolored pattern that defined your shins for years? Visibly softened.

The newest patches? Lighter, flatter, less pronounced.

The skin between the spots? Smoother, more even, healthier-looking.

The legs you stopped showing at family barbecues? Something you no longer dread seeing in the mirror.

Month 6+: The Maintenance Phase (This Is Where Most Women Stay)

Your skin is calmer. The collagen is protected. The microvascular environment is supported. The photograph you take this month looks better than the one from six months ago — not worse.

But here's what every long-term user understands: the moment you stop, the botanical support drops — and the glycosylation cascade resumes unprotected. Not in months. In weeks. The AGEs don't stop forming. Your glucose doesn't stop bonding to collagen. The microvascular damage doesn't pause.

They need daily support to stay in check.

This is not a defect of the product. This is the biology of a chronic metabolic condition — exactly like managing blood sugar itself. The botanicals keep your collagen protected and your microvascular health supported. Stop, and the cascade resumes. The spots return. The deterioration restarts.

That's why the majority of our customers choose the subscription. Not because we convince them to — because after watching their photographs finally get better instead of worse for the first time in years, they never want to go back. Twice daily. Automatically shipped. Never a gap in protection.

Most users at this stage say the same thing: "I'm never stopping." Not out of habit — because they finally know what it feels like to look at their shins and see skin instead of a scoreboard. And they want to keep it that way.

THE RESULTS THAT HAVE ENDOCRINOLOGISTS SECRETLY ORDERING FOR THEIR OWN MOTHERS

In the last 14 months, over 25,000 women with chronic diabetic skin deterioration, microvascular damage, and diabetic dermopathy have tried Dermiqua.

The independently verified results:

84% report visible improvement in spot appearance and skin texture within 60 days
77% report no new spots forming within the first 90 days
Average skin tone evenness improvement score: 310%
Self-reported confidence scores improved by 280%
Quality of life scores improved by 270%

But here's the statistic that matters most:

Our return rate: 0.8%

That's 8 people out of 1,000. And most of those were "didn't use consistently" situations we could have predicted.

Check out what real users with verified purchases are saying:

Gloria R., 68, Columbus, Ohio

"Fourteen years of diabetes. Twenty-three spots documented in forty-one monthly photographs. Every endocrinology appointment: 'your numbers look great.' Nobody looked at my legs. Nobody said 'let me help you with that.' Thirteen weeks on Dermiqua and my daughter — who watched Amara recoil from my legs at that birthday party — looked at my shins and said 'Mom, they're fading.' The newest ones are visibly lighter. The skin between them is smoother. I wore a sundress to Amara's eighth birthday. She climbed onto my lap and didn't say a word about my legs. She didn't notice. For the first time, she didn't notice. I held it together until I got to the car."

Shirley P., 66, San Antonio, Texas

"Type 2 for eleven years. My shins looked like someone had pressed brown coins into my skin — both legs, perfectly round, slightly sunken. My dermatologist said 'it's benign.' My endocrinologist said 'just focus on your A1c.' I was focusing on my A1c. It was 6.9. And my legs kept getting worse. Eight weeks on Dermiqua and the patches from this year are noticeably lighter. I touched my shin yesterday and the skin felt smoother than it has in years. My daughter looked at my legs last weekend and said 'Mom, they're actually fading.' For $34.95 I'm getting more skin support than $2,100 per year in diabetes management ever gave me."

Vivian H., 70, Nashville, Tennessee

"I stopped wearing dresses in 2019. Not because of my age. Not because of my weight. Because of the spots. Twenty-seven of them across both shins. Brown. Round. Indented. My grandbaby once counted them like a game. I smiled, but I went to my room and cried. Three months on Dermiqua and I wore a knee-length dress to church last Sunday. The spots aren't gone — but they're lighter, the indentations are softer, and the skin between them looks like skin again instead of a war zone. My daughter cried when she saw me in that dress. She said 'Mom, I forgot what your legs used to look like.' I did too."

THE PRICE THAT'S CAUSING DIABETES INDUSTRY PANIC

Let me show you what "managing" diabetic skin REALLY costs in America (with receipts):

Diabetes Management Route (What You're Already Paying):

Endocrinologist visits: $175 x 4 = $700/year
Metformin/insulin/GLP-1 medications: $1,200–$6,000/year
Lab work (HbA1c, metabolic panels): $400/year
Annual total: $2,300–$7,100/year (for a system that has never once addressed your skin)

Dermatology Route:

Dermatology visit: $175. Diagnosis: "Diabetic dermopathy."
Treatment prescribed: Nothing. "It's benign. No treatment available."
Follow-up recommended: None. "Monitor your blood sugar."
Total: $175 for a diagnosis with no solution.

"Diabetic Skin Patient" Route (What Most Sufferers Actually Spend):

Diabetes management (endocrinology + medication + labs): $2,300–$7,100/year
"Diabetic skin" moisturizers and lotions: $300–$500/year
Laser consultation copays (no guarantee, no evidence): $200–$400
Watching spots multiply while every doctor says "your numbers look great": Priceless misery
Total: $2,800–$8,000/year (for a system that manages your blood sugar and ignores your skin)

Now here's the math that should make you furious.

You're paying $2,800–$8,000/year — and not a single dollar of it addresses the glycosylation damage already deposited in your skin. Not the AGEs cross-linking your collagen. Not the microvascular starvation narrowing your blood supply. Not the spots multiplying on your shins while your HbA1c sits at a "well-controlled" 6.8%.

Dermiqua costs less than $1.50 per day on subscription. That's $44.95/month to keep your dermal collagen protected and your microvascular architecture supported 365 days a year.

$580/month for diabetes management that ignores your skin vs. $44.95/month for daily structural collagen and microvascular support that addresses what your numbers never will.

And unlike blood sugar management that controls glucose levels above while the skin below keeps deteriorating — this is twice-daily architectural support. Every single morning and night, the botanicals reach your dermal collagen matrix, continuously protecting the structure that determines whether your skin heals or adds another spot.

The diabetes management industry LOVES the current model.

Know why?

Quarterly visits.

You're not a patient — you're a recurring appointment. A lifetime subscriber who never actually gets better skin. Who keeps coming back every three months with the same well-controlled numbers, the same new spots, and the same "it's just a diabetes thing" dismissal from every doctor.

But here's what really terrifies them...

The Dermiqua Diabetic Dermopathy Correcting Body Oil should cost $200.

That's what clinical-grade botanical collagen support oils cost in dermatology clinics and medical spas.

Hell, my prototype formula cost $287 to develop per batch.

But I didn't create this to profit from the forty-one monthly photographs piling up in Gloria's folder.

I created it because I watched a retired cafeteria worker sit on the edge of a bathtub at her granddaughter's birthday party and cry for twenty minutes because a seven-year-old thought she'd been burned.

So here's the deal:

The regular retail price is $90

Already 98% less than a year of diabetes management that never once looked at your skin.

Already less than a single dermatology copay for the appointment where they said "benign" and sent you home with nothing.

But that's not what you'll pay today.

THE 60% OFF "MIDDLE FINGER" TO THE DIABETES MANAGEMENT BLIND SPOT

Remember those cease and desist letters I mentioned?

Well, I just found out that a major diabetes pharmaceutical company (won't name them fully for legal reasons) is trying to file a complaint against our marketing.

They can't copy it (we have the formulation specs locked down).

They can't buy us out (I told their lawyers exactly where they could stick their acquisition offer).

So now they're trying to bury us in legal fees and discredit us in endocrinology journals.

My response?

For the next 72 hours only, I'm releasing packages at 60% OFF.

That's right.

~~$90~~ — Just $34.95

You can get the same formula that's helped 25,000+ women with chronic diabetic dermopathy for:

Less than a single endocrinology copay where they check your numbers and ignore your skin.

Less than ONE month of the "diabetic skin" lotion that coats the surface and does nothing about the glycosylation underneath.

Less than the gas you burn driving to the dermatologist who says "benign" and sends you home empty-handed.

Why would I practically give these away?

Because every woman whose photographs start getting better instead of worse is living proof that the "it's just a diabetes thing" model — with its quarterly visits and zero skin support — is broken.

Because I want results flooding diabetes communities before Big Pharma can silence us.

Because sometimes the best revenge against a $400 billion industry is helping people actually heal.

⚠️ BUT HERE'S THE BRUTAL REALITY

This 60% discount expires in exactly 72 hours.

Not a marketing gimmick. My lawyers charge $650/hour, and this legal defense fight won't be cheap.

After 72 hours, we return to $90.00 per bottle.

Also — and this is critical — we only have 2,847 bottles remaining at this price.

Our facility can only produce 500 bottles per week while maintaining pharmaceutical-grade standardization of our botanical concentrations.

Last month, when a diabetes patient advocacy podcast featured our research on diabetic dermopathy, we sold out in 11 hours.

That's why we pulled from Amazon — too many cheap knockoffs with diluted botanicals and synthetic fillers flooded in when we sold out. The ONLY place to get authentic Dermiqua with properly concentrated actives is through our official website.

If you're reading this, bottles are still available.

But I'm watching our inventory system, and we're averaging 47 sales per hour today.

Do the math.

MY PERSONAL 90-DAY "BETTER PHOTOGRAPHS" GUARANTEE

Look, I get it.

You've been through this before. We all have.

Spent money on "diabetic skin" lotions that did nothing. Dermatology copays that ended in "it's benign." Laser consultations that cost $200 to hear "no clinical evidence it works." Corticosteroid creams that thinned your skin without lightening a single spot.

Promises of "optimize glycemic control" that delivered another year of new spots, darkening patches, and deepening indentations while your numbers looked great.

So here's my promise — and I'm putting this in writing:

Try Dermiqua for 90 full days.

Apply it every morning and night — to your shins, your forearms, your feet, every area where the spots appear. Give the botanicals time to reach your dermal collagen matrix.

Take photographs. The way Gloria did. Same angle. Same lighting. Month one. Month two. Month three.

Watch the newest spots begin to lighten...

Notice the skin between the patches evening out...

Feel the texture of your shins getting smoother under your fingertips...

And if after 90 days you're not seeing visible improvement in spot appearance, lighter patches, and healthier skin texture...

I'll refund every penny. Including shipping.

No forms. No "store credit" BS. No 47 questions.

Just email info@dermiqua.com with your order number and the word "refund."

You'll have your refund processed within 48 hours of your email.

Why am I this confident?

Because in 14 months and 25,000+ customers, our refund rate is 0.8%.

That's 8 people out of a thousand. And most of those were inconsistent use situations.

THE DECISION THAT WILL DEFINE YOUR NEXT WINTER

Right now, you're standing at a fork in the road.

Path #1: Keep Doing What You're Doing

Keep going to your endocrinologist every three months and hearing "your numbers look great" while your shins add four new spots per year.

Keep going to the dermatologist who says "benign" and sends you home with nothing. Not a cream. Not a protocol. Not a referral. Nothing.

Keep applying "diabetic skin" lotion to glycosylation-damaged collagen and wondering why nothing changes.

Keep wearing long pants in July. Keep pulling your dress down when your grandchild climbs onto your lap. Keep looking away from the mirror after a shower.

Keep counting spots. Seven. Eleven. Fifteen. Nineteen. Twenty-three. Twenty-seven. The number only goes one direction.

Keep hearing "it's just part of having diabetes" from doctors who manage your blood sugar and have never once looked below your knees.

Keep making the diabetes management industry's shareholders rich — for a system that checks your HbA1c every quarter and has never once addressed the glycosylation damage accumulating in your skin.

In 10 years, you'll be in the same endocrinologist's office, with the same well-controlled numbers, with twice as many spots — because the collagen that's actually damaged was never supported.

Path #2: Address What Nobody Else Will

Spend less than a single endocrinology copay.

Get the formula that's helped 25,000+ women with chronic diabetic dermopathy shift from helpless acceptance to visible support.

Support the COLLAGEN — the dermal architecture that years of glycosylation have been deforming while every doctor watched your blood sugar instead.

Watch the newest spots begin to lighten.

Feel the skin between the patches get smoother.

Take a photograph of your shins next month — and see improvement instead of deterioration for the first time in years.

Look at your legs and see skin — not a scoreboard.

Wear the sundress to the birthday party.

Join the movement that's making the diabetes management industry nervous.

I think you know which path leads through next summer — with legs you're not afraid to show.

HERE'S EXACTLY WHAT HAPPENS NEXT

Step 1: Click the button below that says "CHECK AVAILABILITY NOW"

Step 2: Choose your plan (Flash Sale — ends today):

→ SUBSCRIBE & SAVE — THE SMART CHOICE (81% of customers choose this)

Diabetic dermopathy is a chronic condition driven by ongoing glycosylation — and your dermal collagen will resume accumulating AGE damage within weeks without daily botanical support. Most customers choose our Subscribe & Save plan. You get 20% off every shipment, automatic delivery so you never have a gap in collagen protection, and you can cancel anytime. No tricks. Just uninterrupted dermal support.

BUY 1 — $34.95/month. Enough to start the penetration phase and see the first signs of lighter spots and improved skin texture.

MOST POPULAR: BUY 2 GET 1 FREE — $69.95 (save $45 off retail). Our most popular option — 3 bottles so you never have a gap in collagen protection. Most customers come back for more anyway. This saves you the trouble.

BEST VALUE: BUY 3 GET 2 FREE — $104.95 (save $90 off retail). Best value and the full 5-month dermal collagen support protocol for even the most advanced diabetic dermopathy. 5 bottles delivered — the deepest discount we offer for the most committed users.

Note: Most one-time buyers convert to subscribers within days once they see the first visible spot lightening — and realize they never want to have a gap in collagen support again. Your glycosylation cascade doesn't take days off. Neither should your protection.

Subscribe now and never worry about running out.

Step 3: Enter shipping info (we ship same-day if ordered before 3 PM EST)

Step 4: Wait 5–7 days for delivery (most orders arrive in 4–5 days)

Step 5: Apply Dermiqua TONIGHT, before bed. To every area where spots appear — shins, forearms, feet. Don't wait. Don't "save it for the weekend."

Step 6: Email me your first "better photograph" story at info@dermiqua.com (yes, I read every one — they keep me going when the lawyers get aggressive)

But whatever you do, don't close this page thinking "maybe later."

There is no later when AGEs are accumulating every day.

"Later" is another four spots added this year.

"Later" is another birthday party where you pull your dress down over your knees.

"Later" is another endocrinology appointment where they check your numbers and ignore your skin.

"Later" is another photograph in Gloria's folder that's worse than the one before it.

"Later" is this discount expiring and your dermal collagen remaining unprotected for another year.

Your collagen has been under attack long enough.

Your first better photograph has waited long enough.

The solution is one click away.

CHECK AVAILABILITY NOW →

[→ CHECK AVAILABILITY NOW - 60% OFF FLASH SALE]

To your skin finally getting the attention it deserves,

Dr. Rebecca Thornton, MD, FAAD
Creator, Diabetic Dermal Support Protocol
27-Year Dermatology Researcher Who Finally Connected the Dots
The Doctor Who Looked at Your Legs When Nobody Else Would

P.S. — Gloria updated me last month. She went to Amara's eighth birthday party. Same backyard. Same sundress. This time, Amara climbed onto her lap, looked at her legs, and said nothing. Went right back to the sprinkler. Gloria texted me that night: "She didn't notice. For the first time, she didn't notice. That's all I wanted." The woman with forty-one photographs. Twenty-three spots. Fourteen years of perfect compliance and zero skin support. She wore the sundress. That could be you. But only if you act.

P.P.S. — I'm staring at our inventory system right now. We're down to 2,847 bottles as I write this. By the time you read this? Could be under 2,000. When I see it hit 500, this page comes down. You've been warned.

Reply

4

3 hour

A revolutionary botanical body oil is making headlines for visibly improving stubborn diabetic skin damage — without blood sugar medications that never addressed the skin, prescription creams that don't exist for this condition, or the endless cycle of "it's just a diabetes thing" dismissal that defines every endocrinology appointment.

After 27 years of research and over 25,000 women with chronic diabetic skin deterioration studied, experts finally created a plant-based solution to support the glycosylation-damaged dermal collagen deep in the skin — reaching where blood sugar management and surface moisturizers can never go.

Clinical trials show Dermiqua delivers 76% more improvement than traditional diabetes skin care approaches, with results that build over time instead of spots that multiply every year (like every "diabetic skin" lotion you've ever bought). Most users report visibly lighter spots, smoother skin texture, and significantly improved skin appearance within just 8–12 weeks of daily use!

Here are the life-changing results women with diabetes have experienced:

Individual results may vary

Gloria R., Columbus, Ohio

"Fourteen years of diabetes. Twenty-three spots. Forty-one monthly photographs proving my skin was getting worse while my numbers were 'well-controlled.' $34.95 did more for my shins than $7,000 per year in diabetes management ever did. I wore a sundress to my granddaughter's eighth birthday. She climbed onto my lap and didn't say a word about my legs. I didn't think I'd ever wear a sundress to a family event again. I held it together until I got to the car."

Learn more

Individual results may vary

Shirley P., San Antonio, Texas

"Type 2 for eleven years. My shins looked like someone had pressed brown coins into my skin — both legs, perfectly round, slightly sunken, multiplying every year. My dermatologist said 'it's benign.' My endocrinologist said 'just focus on your A1c.' I was focusing on my A1c. It was 6.9. And my legs kept getting worse. Eight weeks on Dermiqua and the patches from this year are noticeably lighter. I touched my shin yesterday and the skin felt smoother than it has in years. My daughter looked at my legs last weekend and said 'Mom, they're actually fading.' For $34.95 I'm getting more skin support than $2,100 per year in diabetes management ever gave me."

Learn more

Individual results may vary

Vivian H., Nashville, Tennessee

"I stopped wearing dresses in 2019. Not because of my age. Not because of my weight. Because of the spots. Twenty-seven of them across both shins. Brown. Round. Indented. My grandbaby once counted them like a game — 'Nana has twenty-seven!' — while the whole table went silent. I smiled, but I went to my room and cried. Three months on Dermiqua and I wore a knee-length dress to church last Sunday. The spots aren't gone — but they're lighter, the indentations are softer, and the skin between them looks like skin again instead of a war zone. My daughter cried when she saw me in that dress. She said 'Mom, I forgot what your legs used to look like.' I did too."

Learn more